Related Experiment Video

Updated: Jul 19, 2026

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

Gastroduodenal disorders in children

O Louis-Jacques1, J A Perman

  • 1Department of Pediatrics, University of Maryland, Baltimore, Maryland 21201, USA. olouisjacques@peds.umaryland.edu

Current Opinion in Gastroenterology
|October 13, 2006
PubMed

Insights

The new stool antigen test for Helicobacter pylori infection in children shows promising results in high-risk groups. Further interpretation is needed, but it aids in diagnosing pediatric gastrointestinal issues.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiology
  • Clinical Diagnostics

Background:

  • Guidelines for diagnosing Helicobacter pylori (H. pylori) in children have been published.
  • Delayed gastric emptying is associated with various pediatric disorders and vomiting.
  • Infantile hypertrophic pyloric stenosis and allergic gastroenteropathy are significant pediatric conditions.

Purpose of the Study:

  • Evaluate the efficacy of a new stool antigen test for H. pylori in high-risk pediatric populations.
  • Provide insights into the outcomes of children experiencing dyspeptic symptoms.
  • Discuss recent research on infant gastric enzyme development and pyloric stenosis.

Main Methods:

  • The study involved testing two high-risk pediatric groups using a newly commercialized stool antigen test for H. pylori.
  • Clinical outcomes for children with dyspeptic symptoms were documented.
  • Literature review on H, K-adenosine triphosphatase development and enteric glial cells in pyloric stenosis was conducted.

Main Results:

  • The stool antigen test for H. pylori yielded encouraging results in the evaluated pediatric populations.
  • Data on children with dyspeptic symptoms can help manage parental anxiety.
  • Research suggests allergic gastroenteropathy may be more prevalent in neonates than previously assumed.

Conclusions:

  • The H. pylori stool antigen test is a potentially valuable tool for pediatric diagnosis, though results require cautious interpretation.
  • Understanding dyspeptic symptom outcomes can support clinical practice and parental reassurance.
  • Ongoing research into infant gastrointestinal development and conditions like pyloric stenosis is crucial.

Related Concept Videos

Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...